A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

Scientists at MD Anderson Cancer Center have revealed how ATRX mutations restructure chromatin and activate oncogenic ...

Sure, here is the description with all links and additional text removed: If you found this video enjoyable, kindly show your ...

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

HOUSTON, JULY 1, 2026 ― A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

Biomedical engineers use iPSCs to grow specialized retinal endothelial cells, successfully regenerating damaged eye blood ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...

Ford Motor Co. took an unusually human approach to fixing its stubborn quality problems: It brought back what it calls “gray beard” engineers to help train younger staff and to reprogram the ...

Researchers have identified a vitamin B12–based compound that can cross the blood-brain barrier and home in on glioblastoma tumors. In animal studies, the compound accumulated preferentially in tumor ...

For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...

A newly discovered molecule, OLE, restored the brain’s immune cells to a more protective state in Alzheimer’s disease models. The treatment reduced the accumulation of toxic plaques and improved ...